These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26919249)

  • 1. Elevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia.
    Wu F; Ding S; Li X; Wang H; Liu S; Wu H; Bi D; Ding K; Lu J
    Oncotarget; 2016 Mar; 7(11):12053-62. PubMed ID: 26919249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue.
    Du Z; Fujiyama C; Chen Y; Masaki Z
    Chin Med J (Engl); 2003 Dec; 116(12):1936-9. PubMed ID: 14687488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin C supplementation prevents testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1alpha.
    Li SH; Ryu JH; Park SE; Cho YS; Park JW; Lee WJ; Chun YS
    J Nutr Biochem; 2010 Sep; 21(9):801-8. PubMed ID: 19716283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue.
    Lekas A; Lazaris AC; Deliveliotis C; Chrisofos M; Zoubouli C; Lapas D; Papathomas T; Fokitis I; Nakopoulou L
    Anticancer Res; 2006; 26(4B):2989-93. PubMed ID: 16886625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor in prostate cancer and its significance].
    Wang L; Chen ZJ; Wang QT; Cao WF; Jian Y; Wang SX; Zhang BH
    Zhonghua Nan Ke Xue; 2006 Jan; 12(1):57-9. PubMed ID: 16483162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of the impact of ischemic change in benign prostatic hyperplasia.
    Jin Cho W; Pyo JS
    Pathol Res Pract; 2020 Jan; 216(1):152694. PubMed ID: 31734054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic role of HIF-1α in prostate hyperplasia in the presence of chronic inflammation.
    Kim HJ; Park JW; Cho YS; Cho CH; Kim JS; Shin HW; Chung DH; Kim SJ; Chun YS
    Biochim Biophys Acta; 2013 Jan; 1832(1):183-94. PubMed ID: 22986049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histological changes of the prostate and acute urinary retention in patients with benign prostatic hyperplasia].
    Bao QB; He GH; Liu GY; Zhang CG; Yang C
    Zhonghua Nan Ke Xue; 2013 Sep; 19(9):811-4. PubMed ID: 24386860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
    Matsuda T; Fujime M; Suda K
    Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia.
    Lekas AG; Lazaris AC; Chrisofos M; Papatsoris AG; Lappas D; Patsouris E; Deliveliotis C
    Urology; 2006 Aug; 68(2):436-41. PubMed ID: 16904480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer.
    Fraga A; Ribeiro R; Coelho A; Vizcaíno JR; Coutinho H; Lopes JM; Príncipe P; Lobato C; Lopes C; Medeiros R
    BMC Urol; 2017 Jan; 17(1):12. PubMed ID: 28143503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress promotes benign prostatic hyperplasia.
    Vital P; Castro P; Ittmann M
    Prostate; 2016 Jan; 76(1):58-67. PubMed ID: 26417670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of ROS in prostatic stromal cells under hypoxic environment.
    Ren H; Li X; Cheng G; Li N; Hou Z; Suo J; Wang J; Za X
    Aging Male; 2015 Jun; 18(2):84-8. PubMed ID: 25746207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of NKX3.1 in benign prostatic hyperplasia.
    Irer B; Toylu A; Aslan G; Celebi I; Yorukoglu K; Atabey N
    Urology; 2009 May; 73(5):1140-4. PubMed ID: 18597829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia.
    Berger AP; Kofler K; Bektic J; Rogatsch H; Steiner H; Bartsch G; Klocker H
    Prostate; 2003 Sep; 57(1):57-65. PubMed ID: 12886524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study on the penetrability of trypan blue to the rat prostate].
    Wang H; Chen Z; Zhu Y
    Zhonghua Nan Ke Xue; 2004 Nov; 10(11):811-4. PubMed ID: 15595679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysis.
    Morlock R; Goodwin B; Gomez Rey G; Eaddy M
    Clin Ther; 2013 May; 35(5):624-33. PubMed ID: 23583026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased and localized accumulation of chondroitin sulphate proteoglycans in the hyperplastic human prostate.
    Cardoso LE; Falcão PG; Sampaio FJ
    BJU Int; 2004 Mar; 93(4):532-8. PubMed ID: 15008724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
    Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.